Back to a16z Capital Management, L.L.C.
a16z Capital Management, L.L.C.
Q3 2026 13F filing
Updated 6 days ago24 disclosed positions worth $19.9B
Portfolio value
$19.9B
Total holdings
24
New positions
0
Closed positions
0
Increased
0
Decreased
0
Turnover
—
Filed
2026-11-16
Full holdings
Every line item disclosed in Q3 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | S SPACE EXPLORATION TECHN CORP | $18.4B | 121.78M | 92.35% | — |
| 2 | N NAVAN INC | $592.3M | 28.22M | 2.98% | — |
| 3 | ? N/A BRAVEHEART BIO INC | $206.7M | 10.23M | 1.04% | — |
| 4 | R REVOLUTION MEDICINES INC | $160.7M | 782.9K | 0.81% | — |
| 5 | F FREENOME INC | $87.8M | 5.57M | 0.44% | — |
| 6 | L NEUTRON HOLDINGS INC | $80.3M | 2.85M | 0.40% | — |
| 7 | B BLOCK INC | $74.8M | 1.02M | 0.38% | — |
| 8 | ? N/A SCRIBE THERAPEUTICS INC | $56.7M | 3.08M | 0.29% | — |
| 9 | F FIGMA INC | $53.9M | 2.57M | 0.27% | — |
| 10 | M MAZE THERAPEUTICS INC | $46.3M | 1.70M | 0.23% | — |
| 11 | ? N/A STANDARD NUCLEAR INC | $34.5M | 2.92M | 0.17% | — |
| 12 | ? N/A DAMORA THERAPEUTICS INC | $26.3M | 1.24M | 0.13% | — |
| 13 | B BIOAGE LABS INC | $22.9M | 3.23M | 0.12% | — |
| 14 | E ERASCA INC | $21M | 1.43M | 0.11% | — |
| 15 | M META PLATFORMS INC | $15.2M | 21.0K | 0.08% | — |
| 16 | R ROBLOX CORP | $11.6M | 274.6K | 0.06% | — |
| 17 | C CAMP4 THERAPEUTICS CORP | $8.6M | 2.13M | 0.04% | — |
| 18 | A AKTIS ONCOLOGY INC | $8.1M | 415.0K | 0.04% | — |
| 19 | ? N/A BITGO HOLDINGS INC | $4.9M | 666.4K | 0.02% | — |
| 20 | ? N/A NAUTILUS BIOTECHNOLOGY INC | $3.8M | 2.66M | 0.02% | — |
| 21 | ? N/A BLOSSOMHILL THERAPEUTICS INC | $2.3M | 125.0K | 0.01% | — |
| 22 | K KAILERA THERAPEUTICS INC | $1.6M | 140.0K | 0.01% | — |
| 23 | D GINKGO BIOWORKS HOLDINGS INC | $1.4M | 108.6K | 0.01% | — |
| 24 | ? N/A IP STRATEGY HOLDINGS INC | $13K | 4.1K | 0.00% | — |